Logo image of DX

DYNEX CAPITAL INC (DX) Stock Fundamental Analysis

USA - NYSE:DX - US26817Q8868 - REIT

12.5199 USD
-0.01 (-0.08%)
Last: 9/15/2025, 12:26:03 PM
Fundamental Rating

4

Overall DX gets a fundamental rating of 4 out of 10. We evaluated DX against 62 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. DX has a medium profitability rating, but doesn't score so well on its financial health evaluation. DX is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

DX had positive earnings in the past year.
In the past year DX had a positive cash flow from operations.
Of the past 5 years DX 4 years were profitable.
DX had a positive operating cash flow in each of the past 5 years.
DX Yearly Net Income VS EBIT VS OCF VS FCFDX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

DX's Return On Assets of 0.50% is fine compared to the rest of the industry. DX outperforms 67.74% of its industry peers.
The Return On Equity of DX (3.54%) is better than 62.90% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.04%, DX is doing worse than 66.13% of the companies in the same industry.
Industry RankSector Rank
ROA 0.5%
ROE 3.54%
ROIC 0.04%
ROA(3y)1.61%
ROA(5y)2.5%
ROE(3y)7.47%
ROE(5y)11.89%
ROIC(3y)N/A
ROIC(5y)N/A
DX Yearly ROA, ROE, ROICDX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

With an excellent Profit Margin value of 15.04%, DX belongs to the best of the industry, outperforming 82.26% of the companies in the same industry.
In the last couple of years the Profit Margin of DX has declined.
With a Operating Margin value of 1.50%, DX is not doing good in the industry: 66.13% of the companies in the same industry are doing better.
DX has a Gross Margin of 12.68%. This is in the lower half of the industry: DX underperforms 67.74% of its industry peers.
In the last couple of years the Gross Margin of DX has declined.
Industry RankSector Rank
OM 1.5%
PM (TTM) 15.04%
GM 12.68%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-37.42%
PM growth 5YN/A
GM growth 3Y-75.33%
GM growth 5Y-47.03%
DX Yearly Profit, Operating, Gross MarginsDX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K -4K

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DX is destroying value.
DX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for DX has been increased compared to 5 years ago.
Compared to 1 year ago, DX has an improved debt to assets ratio.
DX Yearly Shares OutstandingDX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
DX Yearly Total Debt VS Total AssetsDX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

DX has an Altman-Z score of -0.92. This is a bad value and indicates that DX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.92, DX is doing worse than 79.03% of the companies in the same industry.
DX has a debt to FCF ratio of 168.78. This is a negative value and a sign of low solvency as DX would need 168.78 years to pay back of all of its debts.
DX has a Debt to FCF ratio of 168.78. This is comparable to the rest of the industry: DX outperforms 45.16% of its industry peers.
A Debt/Equity ratio of 5.36 is on the high side and indicates that DX has dependencies on debt financing.
DX's Debt to Equity ratio of 5.36 is in line compared to the rest of the industry. DX outperforms 41.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.36
Debt/FCF 168.78
Altman-Z -0.92
ROIC/WACC0.01
WACC5.9%
DX Yearly LT Debt VS Equity VS FCFDX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.05 indicates that DX may have some problems paying its short term obligations.
The Current ratio of DX (0.05) is worse than 83.87% of its industry peers.
DX has a Quick Ratio of 0.05. This is a bad value and indicates that DX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of DX (0.05) is worse than 83.87% of its industry peers.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
DX Yearly Current Assets VS Current LiabilitesDX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 145.74% over the past year.
Measured over the past years, DX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -18.72% on average per year.
The Revenue has grown by 35.01% in the past year. This is a very strong growth!
DX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.32% yearly.
EPS 1Y (TTM)145.74%
EPS 3Y-18.72%
EPS 5YN/A
EPS Q2Q%283.33%
Revenue 1Y (TTM)35.01%
Revenue growth 3Y68.26%
Revenue growth 5Y13.32%
Sales Q2Q%1697.05%

3.2 Future

The Earnings Per Share is expected to grow by 73.39% on average over the next years. This is a very strong growth
Based on estimates for the next years, DX will show a very strong growth in Revenue. The Revenue will grow by 149.36% on average per year.
EPS Next Y388.97%
EPS Next 2Y136.23%
EPS Next 3Y73.39%
EPS Next 5YN/A
Revenue Next Year748.76%
Revenue Next 2Y288.89%
Revenue Next 3Y149.36%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DX Yearly Revenue VS EstimatesDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 100M 200M 300M
DX Yearly EPS VS EstimatesDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 29.12, the valuation of DX can be described as expensive.
DX's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of DX to the average of the S&P500 Index (27.30), we can say DX is valued inline with the index average.
A Price/Forward Earnings ratio of 8.33 indicates a reasonable valuation of DX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DX indicates a somewhat cheap valuation: DX is cheaper than 66.13% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of DX to the average of the S&P500 Index (22.73), we can say DX is valued rather cheaply.
Industry RankSector Rank
PE 29.12
Fwd PE 8.33
DX Price Earnings VS Forward Price EarningsDX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

79.03% of the companies in the same industry are more expensive than DX, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as DX.
Industry RankSector Rank
P/FCF 30.7
EV/EBITDA 158.88
DX Per share dataDX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

DX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DX's earnings are expected to grow with 73.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.07
PEG (5Y)N/A
EPS Next 2Y136.23%
EPS Next 3Y73.39%

5

5. Dividend

5.1 Amount

DX has a Yearly Dividend Yield of 16.24%, which is a nice return.
DX's Dividend Yield is rather good when compared to the industry average which is at 11.50. DX pays more dividend than 93.55% of the companies in the same industry.
DX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 16.24%

5.2 History

The dividend of DX decreases each year by -11.72%.
DX has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-11.72%
Div Incr Years0
Div Non Decr Years0
DX Yearly Dividends per shareDX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

5.3 Sustainability

DX pays out 288.22% of its income as dividend. This is not a sustainable payout ratio.
DP288.22%
EPS Next 2Y136.23%
EPS Next 3Y73.39%
DX Yearly Income VS Free CF VS DividendDX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M
DX Dividend Payout.DX Dividend Payout, showing the Payout Ratio.DX Dividend Payout.PayoutRetained Earnings

DYNEX CAPITAL INC

NYSE:DX (9/15/2025, 12:26:03 PM)

12.5199

-0.01 (-0.08%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)07-21 2025-07-21/bmo
Earnings (Next)10-20 2025-10-20/bmo
Inst Owners43.11%
Inst Owner Change45.54%
Ins Owners0.9%
Ins Owner Change4.22%
Market Cap1.57B
Analysts84
Price Target14.2 (13.42%)
Short Float %5.3%
Short Ratio1.67
Dividend
Industry RankSector Rank
Dividend Yield 16.24%
Yearly Dividend1.67
Dividend Growth(5Y)-11.72%
DP288.22%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-22 2025-08-22 (0.17)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-22.33%
Min EPS beat(2)-31.42%
Max EPS beat(2)-13.24%
EPS beat(4)1
Avg EPS beat(4)-62.16%
Min EPS beat(4)-246.74%
Max EPS beat(4)42.78%
EPS beat(8)2
Avg EPS beat(8)-77.17%
EPS beat(12)2
Avg EPS beat(12)-166.27%
EPS beat(16)3
Avg EPS beat(16)-125.15%
Revenue beat(2)0
Avg Revenue beat(2)-13.38%
Min Revenue beat(2)-24.66%
Max Revenue beat(2)-2.1%
Revenue beat(4)0
Avg Revenue beat(4)-40.51%
Min Revenue beat(4)-83.68%
Max Revenue beat(4)-2.1%
Revenue beat(8)3
Avg Revenue beat(8)-83.91%
Revenue beat(12)5
Avg Revenue beat(12)-50.42%
Revenue beat(16)6
Avg Revenue beat(16)-38.31%
PT rev (1m)0.6%
PT rev (3m)3.73%
EPS NQ rev (1m)0.46%
EPS NQ rev (3m)22.13%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)15.33%
Revenue NQ rev (1m)15.33%
Revenue NQ rev (3m)55.01%
Revenue NY rev (1m)12.52%
Revenue NY rev (3m)15.45%
Valuation
Industry RankSector Rank
PE 29.12
Fwd PE 8.33
P/S 4.14
P/FCF 30.7
P/OCF 30.7
P/B 0.97
P/tB 0.97
EV/EBITDA 158.88
EPS(TTM)0.43
EY3.43%
EPS(NY)1.5
Fwd EY12.01%
FCF(TTM)0.41
FCFY3.26%
OCF(TTM)0.41
OCFY3.26%
SpS3.02
BVpS12.84
TBVpS12.84
PEG (NY)0.07
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.5%
ROE 3.54%
ROCE 0.34%
ROIC 0.04%
ROICexc 0.05%
ROICexgc 0.05%
OM 1.5%
PM (TTM) 15.04%
GM 12.68%
FCFM 13.5%
ROA(3y)1.61%
ROA(5y)2.5%
ROE(3y)7.47%
ROE(5y)11.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-37.42%
PM growth 5YN/A
GM growth 3Y-75.33%
GM growth 5Y-47.03%
F-Score5
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 5.36
Debt/FCF 168.78
Debt/EBITDA 1130.7
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.02
Cash Conversion 669.93%
Profit Quality 89.78%
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z -0.92
F-Score5
WACC5.9%
ROIC/WACC0.01
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)145.74%
EPS 3Y-18.72%
EPS 5YN/A
EPS Q2Q%283.33%
EPS Next Y388.97%
EPS Next 2Y136.23%
EPS Next 3Y73.39%
EPS Next 5YN/A
Revenue 1Y (TTM)35.01%
Revenue growth 3Y68.26%
Revenue growth 5Y13.32%
Sales Q2Q%1697.05%
Revenue Next Year748.76%
Revenue Next 2Y288.89%
Revenue Next 3Y149.36%
Revenue Next 5YN/A
EBIT growth 1Y112.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-43.71%
FCF growth 3Y-53.91%
FCF growth 5Y-39.34%
OCF growth 1Y-43.71%
OCF growth 3Y-53.91%
OCF growth 5Y-39.34%